Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tehran Chemie Pharmaceutical is a prominent Iranian pharmaceutical manufacturer founded in 1964. The company focuses on the production of high-quality generic medicines across a broad spectrum of therapeutic categories, including cardiovascular, gastrointestinal, and central nervous system treatments. With a manufacturing facility that adheres to international Good Manufacturing Practice (GMP) standards, Tehran Chemie produces various formulations such as tablets, capsules, and oral liquids. The firm is a key supplier to the Iranian healthcare system and maintains a significant presence on the Tehran Stock Exchange. Its portfolio includes well-known generic versions of essential medications, supporting both domestic demand and regional export initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tehran Chemie Pharmaceutical.